| Name | CRISPR Gene Editing for Parkinson's Disease |
| Summary | Comprehensive overview of CRISPR-based gene editing therapies for Parkinson's disease, covering delivery mechanisms, target genes (LRRK2, GBA, SNCA), preclinical results, and clinical prospects. |